Nanoneedle‐Based Electroporation for Efficient Manufacturing of Human Primary Chimeric Antigen Receptor Regulatory T‐Cells
Ningjia Sun(King's College London), Ciro Chiappini(King's College London), Panicos Shangaris(St Thomas' Hospital), Cristiano Scottà(King's College London), Qi Peng(Guy's Hospital), Cong Wang(King's College London), Yikai Wang(King's College London), Xi Lü(Uppsala University), Samuel McLennan(King's College London), Giovanna Lombardi(King's College London), Chenlei Gu(King's College London), William Edwards(King's College London), Daniela Mastronicola(King's College London)
Cited by 11
Related Papers
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Developing in vitro expanded CD45RA<sup>+</sup>regulatory T cells as an adoptive cell therapy for Crohn's disease
|Gut|2015|194